Vimab Group AB (publ) (STO:VIMAB)

Vimab Group AB Statistics

Total Valuation

Vimab Group AB has a market cap or net worth of SEK 66.63 million. The enterprise value is 162.95 million.

Market Cap	66.63M
Enterprise Value	162.95M

Important Dates

The next estimated earnings date is Thursday, March 12, 2026.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Vimab Group AB has 26.55 million shares outstanding. The number of shares has increased by 11.33% in one year.

Current Share Class	26.55M
Shares Outstanding	26.55M
Shares Change (YoY)	+11.33%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	29.68%
Owned by Institutions (%)	n/a
Float	6.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.21
PB Ratio	-9.35
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.79
EV / Sales	0.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.67

Financial Position

The company has a current ratio of 0.49

Current Ratio	0.49
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.40
Interest Coverage	-4.13

Financial Efficiency

Return on equity (ROE) is -324.48% and return on invested capital (ROIC) is -34.25%.

Return on Equity (ROE)	-324.48%
Return on Assets (ROA)	-18.39%
Return on Invested Capital (ROIC)	-34.25%
Return on Capital Employed (ROCE)	-1,205.41%
Weighted Average Cost of Capital (WACC)	9.14%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	193
Asset Turnover	1.12
Inventory Turnover	4.35

Taxes

Income Tax	-880,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.01% in the last 52 weeks. The beta is -0.92, so Vimab Group AB's price volatility has been lower than the market average.

Beta (5Y)	-0.92
52-Week Price Change	-74.01%
50-Day Moving Average	3.81
200-Day Moving Average	6.28
Relative Strength Index (RSI)	20.43
Average Volume (20 Days)	15,894

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vimab Group AB had revenue of SEK 315.14 million and -90.86 million in losses. Loss per share was -3.57.

Revenue	315.14M
Gross Profit	58.34M
Operating Income	-82.87M
Pretax Income	-97.56M
Net Income	-90.86M
EBITDA	-26.72M
EBIT	-82.87M
Loss Per Share	-3.57

Balance Sheet

The company has 10.06 million in cash and 106.38 million in debt, with a net cash position of -96.32 million or -3.63 per share.

Cash & Cash Equivalents	10.06M
Total Debt	106.38M
Net Cash	-96.32M
Net Cash Per Share	-3.63
Equity (Book Value)	-7.13M
Book Value Per Share	-0.27
Working Capital	-124.36M

Cash Flow

In the last 12 months, operating cash flow was -42.34 million and capital expenditures -2.06 million, giving a free cash flow of -44.39 million.

Operating Cash Flow	-42.34M
Capital Expenditures	-2.06M
Free Cash Flow	-44.39M
FCF Per Share	-1.67

Margins

Gross margin is 18.51%, with operating and profit margins of -26.30% and -28.83%.

Gross Margin	18.51%
Operating Margin	-26.30%
Pretax Margin	-30.96%
Profit Margin	-28.83%
EBITDA Margin	-8.48%
EBIT Margin	-26.30%
FCF Margin	n/a

Dividends & Yields

Vimab Group AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.33%
Shareholder Yield	-11.33%
Earnings Yield	-136.37%
FCF Yield	-66.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Vimab Group AB has an Altman Z-Score of -1.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.43
Piotroski F-Score	2